Additional file 4 of Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
posted on 2022-01-05, 04:37authored byMin Fan, Adrienne Y. L. Chan, Vincent K. C. Yan, Xinning Tong, Lauren K. W. Lau, Eric Y. F. Wan, Eliza Y. T. Tam, Patrick Ip, Terry Y. Lum, Ian C. K. Wong, X. Li
Additional file 4. Proportion of orphan drugs affected by severe postmarketing safety events
Funding
lks faculty of medicine, university of hong kong department of medicine, university of hong kong